Daniel L Zheng - FDA Investigator Report

Overview Statistics

26
Total Inspections
24
Total 483s Issued
4
Warning Letters Issued

Inspection Details

Longest Inspection: 288 days
Shortest Inspection: 1 days
Average Length: 30.8 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Daniel L Zheng's Recent Inspections

DateCompanyCityCountryFEI Number483
2025-02-25Alnylam Pharmaceuticals Inc.CambridgeUnited States3013754451
2025-01-17Rentschler Biopharma Inc.MilfordUnited States3003282293
2024-11-07Milbar Laboratories, Inc.East HavenUnited States2435254
2024-07-29Denison Pharmaceuticals, LLCLincolnUnited States1210580
2024-05-17Novel Laboratories, Inc. d.b.a Lupin SomersetSomersetUnited States3006271438
2024-03-22MSN Laboratories Private LimitedSangareddyIndia3008656542
2024-03-15Kekule Pharma LimitedJinnaramIndia3009261338
2024-02-15EyePoint Pharmaceuticals, Inc.WatertownUnited States3005508657
2023-12-22Eugia US Manufacturing LLCEast WindsorUnited States3015534630
2023-10-06Apothecus Pharmaceutical Corp.HicksvilleUnited States3001746542

Sign Up to get the complete report.

Download 483s and EIRs for Daniel L Zheng

Daniel L Zheng - Co-Inspectors

Daniel L Zheng's Active Locations

  • United States
  • India

Daniel L Zheng's Year-wise Inspection Count

  • 2020:1 inspections
  • 2021:3 inspections
  • 2022:9 inspections
  • 2023:5 inspections
  • 2024:6 inspections
  • 2025:2 inspections
Last Updated: 2025-05-14 06:11:22